NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. INSPRA® (in-spra) Eplerenone Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Inspra. It does not contain all the available information….
Read More
Here’s where efforts to end HIV in eastern and southern Africa must focus
The World AIDS Day commemoration of 2020 took place in the midst of a global pandemic. It served as another reminder that people are not only susceptible to pathogens, but to the political, social and economic inequities that determine vulnerability…
Read More
How the vaginal microbiome may affect HIV prevention
Healthy Lactobacillus bacteria in the vagina are critical for women’s health, but the accumulation of additional bacterial genera can imbalance the vaginal ecosystem. Such an imbalance may result in bacterial metabolism of drugs designed to prevent HIV infection, thereby decreasing…
Read More
Millions of people are on treatment for HIV: Why are so many still dying?
Twenty years ago, treatment for HIV was a rare luxury in South Africa. Exorbitant costs and President Thabo Mbeki’s government’s fierce opposition to providing antiretroviral treatment (ART) kept it out of the public sector. They were terrible days. Many lives…
Read More
Many practitioners are not prescribing HIV prevention medication, study finds
Only about 54% of medical practitioners surveyed say they have prescribed pre-exposure prophylaxis, or PrEP, to HIV-vulnerable patients, according to a new study by a Vanderbilt University Medical Center investigator. The study, led by Ashley Leech, Ph.D., assistant professor of…
Read More
Insurer, insured costs for HIV PrEP rising in the United States
(HealthDay)—From 2014 to 2018, there were increases noted in third-party and out-of-pocket (OOP) payments per 30 tenofovir disoproxil fumarate with emtricitabine (TDF-FTC) tablets for HIV preexposure prophylaxis (PrEP), according to a study published online Sept. 8 in the Annals of…
Read More
Researchers are striving to understand the complexities of living with HIV and acquiring COVID-19
Every day, she donned a mask and was vigilant about washing her hands or using hand sanitizer which made the ensuing fever, headaches, sore throat and COVID-19 diagnosis startling. Anna (a pseudonym for privacy protection) has been living with HIV…
Read More
New study supports more frequent HIV screening among high-risk young men who have sex with men
A new study has found that HIV screening every three months compared to annually will improve clinical outcomes and be cost-effective among high-risk young men who have sex with men (YMSM) in the United States. The report, led by researchers…
Read More
HIV may not worsen COVID-19 outlook
People with HIV who were hospitalized with COVID-19 didn’t have worse results than COVID-19 patients without HIV, new research shows. “Throughout the pandemic, we’ve suspected that immunocompromised patients, such as those with HIV, could be at a higher risk for…
Read More
“The Virus will remain” a Top virologist, Streeck doubts looking at the success of the Vaccine
The Bonn virologist Hendrik Streeck doubts that it will be in the foreseeable future, an effective vaccine against the Coronavirus. “Against HIV over 500 vaccines were constructed, a few effectiveness been tested, but none has worked,” said the Director of…
Read More